Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?
Clinical Neurology and Neurosurgery(2020)
摘要
•MS has been associated with an increased risk for VTE.•In our cases, DMF was a possible triggering factor for PE.•High number of VTE cases was found on adverse event reporting systems.•Further work is needed to establish DMTs role in VTE.
更多查看译文
关键词
Dimethyl fumarate,Pulmonary embolism,Venous thromboembolism,Multiple sclerosis,Disease modifying treatment
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要